Table 4.
Logistic regression analysis of factors associated with END in the BAD and CSVD subgroups.
| CSVD | BAD | |||
|---|---|---|---|---|
| Adjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |
| Age | 0.904 (0.784–1.042) | 0.165 | 1.033 (0.950–1.124) | 0.445 |
| Initial NIHSS | 0.941 (0.484–1.829) | 0.858 | 1.095 (0.756–1.586) | 0.631 |
| NLR | 1.489 (0.649–3.417) | 0.347 | 1.819 (1.049–3.153) | 0.033 |
| Lesion diameter | 1.534 (0.990–2.376) | 0.055 | 1.122 (0.799–1.577) | 0.506 |
| FBG | 1.092 (0.727–1.641) | 0.672 | 0.952 (0.707–1.281) | 0.743 |
| 2hPBG | 1.000 (0.682–1.467) | 0.999 | 1.085 (0.791–1.487) | 0.613 |
| eGFR | 0.955 (0.900–1.012) | 0.121 | 1.026 (0.972–1.084) | 0.352 |
NIHSS, national institutes of health stroke scale; NLR, neutrophil-lymphocyte ratio; BAD, branch atheromatous disease; FBG, fasting blood glucose; 2hPBG, 2-hour postprandial blood glucose; eGFR, estimated glomerular filtration rate.